Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
- Conditions
- Cytomegalovirus Infections
- Registration Number
- NCT06522880
- Lead Sponsor
- University of Massachusetts, Worcester
- Brief Summary
The goal of STAGE I of the CMV TransmIT Study is to determine the prevalence of CMV shedding in children up to and including 36 months of age in large group childcare centers and in staff who regularly work at the center. Participants will complete a health survey and provide one saliva sample for CMV PCR testing. In addition, infrastructure for the study will be developed (e.g. community engagement to build the network of centers, data pipelines, digital platform, sampling workflows) and participant sample collection at home will be piloted. These activities will inform the design of STAGE II.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of CMV shedding Stage I up to 2 years Prevalence of CMV shedding in children and childcare center staff. Shedding measured by CMV PCR on saliva.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UMass Chan Medical School
🇺🇸Worcester, Massachusetts, United States
UMass Chan Medical School🇺🇸Worcester, Massachusetts, United States